Dishman Specialty Chemicals
Ahmedabad, India· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A global CDMO providing development and manufacturing services for complex small molecule APIs, including highly potent compounds and vitamin D analogues.
Broad PharmaceuticalHealthcarePersonal Care
Technology Platform
Integrated development and manufacturing platform for complex small molecules, with specialized expertise in Highly Potent API (HPAPI) handling, vitamin D analogue synthesis, and quaternary ammonium chemistry.
Opportunities
Growth in outsourcing of complex and highly potent API manufacturing, expansion of its niche product portfolio (e.g., vitamin D analogues), and leveraging its global regulatory approvals to capture market share in regulated markets.
Risk Factors
Intense competition in the CDMO space, operational and compliance risks across multiple international facilities, client concentration risk, and vulnerability to fluctuations in pharmaceutical R&D investment.
Competitive Landscape
Competes with global CDMOs like Lonza, Cambrex, and Piramal Pharma Solutions, as well as Indian peers like Divi's Laboratories and Laurus Labs. Differentiation is based on specific expertise in HPAPIs and vitamin D chemistry, integrated service offerings, and a cost-competitive global footprint.